Vanda Pharmaceuticals | VNDA - Pre Tax Profit


Vanda Pharmaceuticals reported $-22.92M in Pre-Tax Profit for its fiscal quarter ending in December of 2024.





Pre Tax Profit Change Date
Acadia Pharmaceuticals USD 46.47M 42.49M Jun/2026
Agios Pharmaceuticals USD -99.11M 9.94M Mar/2026
Akebia Therapeutics USD -11.24M 12.39M Dec/2025
Alnylam Pharmaceuticals USD 177.81M 43.85M Jun/2026
Anika Therapeutics USD 764K 3M Dec/2025
Arrowhead Research USD -178.9M 41.34M Jun/2026
AstraZeneca USD 4.81B 894M Jun/2026
Bristol-Myers Squibb USD 4.99B 1.75B Jun/2026
Eli Lilly USD 8.85B 583.8M Mar/2026
Enanta Pharmaceuticals USD -22.71M 95.08M Dec/2024
Halozyme Therapeutics USD 180.33M 281.18M Mar/2026
Heron Therapeutics USD -2.95M 14.54M Dec/2025
Insmed USD -11.37M 150.72M Jun/2026
J&J USD 7.67B 988M Sep/2026
Lexicon Pharmaceuticals USD -12.77M 16.02M Sep/2025
Ligand Pharmaceuticals USD -24.26M 81.04M Mar/2026
Merck USD -3.53B 6.95B Mar/2026
Minerva Neurosciences USD 22.51M 30.74M Sep/2024
Moderna USD -1.33B 535M Mar/2026
Novartis USD 3.84B 1.33B Mar/2026
Pfizer USD -653M 5.84B Jun/2026
PTC Therapeutics USD -2.46M 136.62M Mar/2026
Puma Biotechnology USD 20.61M 24.76M Sep/2024
Sangamo BioSciences USD -36.05M 12.94M Jun/2024
Sanofi EUR 837M 1.17B Jun/2026
Takeda JPY 162.72B 215.2B Jun/2026
Teva Pharmaceutical Industries USD -455M 1.21B Jun/2026
Ultragenyx Pharmaceutical USD -91M 93M Jun/2026
Vanda Pharmaceuticals USD -22.92M 16.68M Dec/2024
Veracyte USD 26.52M 3.45M Jun/2026